Searched for
GLENMARK PHARMACEUTICALS USA
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Glenmark acquires Acetylcysteine injection, launches in US marketGlenmark Pharmaceuticals Ltd acquired the generic version of Acetylcysteine injection from Aspen Pharma USA Inc and launched it in the US m...
- Glenmark Pharma gets USFDA nod for generic drugThe approval granted by the US Food & Drug Administration (USFDA) is for bicardipine hydrochloride capsules of strengths 20 mg and 30 mg, G...
- Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drugThese are generic version of Tecfidera Capsules, 120 mg and 240 mg, of Biogen Inc.
- Glenmark gets USFDA nod for plaque psoriasis treatment drugThe approved product is a generic version of Olux-E Foam, 0.05 per cent.
- Glenmark gets USFDA nod for psoriasis sprayGlenmark Pharmaceuticals Inc, USA has received final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propio...
- USFDA gives final nod to Glenmark Pharma for anti-herpes drugGlenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Acyclovir Oint...
- Glenmark Pharma gets USFDA approval for skin cream genericAccording to IMS Health sales data for the 12 months to May 2017, Desonide Cream, 0.05 per cent, achieved annual sales of approximately USD...
- Glenmark gets USFDA nod for skin ointmentGlenmark's current portfolio consists of 113 products authorised for distribution in the US marketplace and approximately 64 ANDA's pending...
- Glenmark gets tentative nod from USFDA for Fingolimod capsules"Glenmark Pharmaceuticals USA has been granted tentative approval by the USFDA for Fingolimod capsules, 0.5 mg, the generic version of Gile...
- Glenmark Pharma gets USFDA nod for anti-fungal ointmentGlenmark Pharmaceuticals USA has been granted final approval by the US Food & Drug Administration (USFDA) for the "nystatin and triamcinolo...
- Glenmark gets USFDA nod for contraceptive tabletsGlenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl estrad...
- Glenmark gets USFDA nod for contraceptive tabletsApproval has been granted for generic version of Ortho Tri-cyclen Lo tablets of Janssen Pharmaceuticals, Inc.
- Glenmark gets USFDA nod for fungal infections treatment drugGlenmark Pharmaceuticals said it has received final approval from the US health regulator for Voriconazole Tablets, used to treat fungal in...
- Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
- Glenmark gets USFDA nod for post-menopause osteoporosis drugThe approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenma...
- Glenmark faces patent infringement suit in USGlenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc to sell generic version of Treanda.
- Glenmark gets USFDA nod for generic Desoximetasone ointmentThe Desoximetasone Ointment USP is the generic version of Taro Pharmaceuticals USA Inc's Topicort and shipping will commence immediately, G...
- Glenmark gets $15 mn plant upgradation advance from SalixGlenmark Pharmaceuticals on Tuesday said it has received USD 15 million (over Rs 65 crore) from Salix Pharmaceuticals Inc, USA.
- Glenmark enters into licence, supply pact with Taro PharmaPharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...
Load More
